Heterogeneity and oxidation status of commercial human albumin preparations in clinical use

Critical Care Medicine

Volumn 33, Issue 7, 2005, Pages 1638-1641

  Bar Or, David ^a,d   Bar Or, Raphael ^a,d   Rael, Leonard T ^a   Gardner, David K ^b   Slone, Denetta S ^c   Craun, Michael L ^c  

^a SWEDISH MEDICAL CENTER   (United States)

^b National Foundation for Fertility Research   (United States)

^c Trauma Services   (United States)

^d DMI BioSciences Inc   (United States)

Author keywords

Cysteinylation; Human serum albumin; Nitrosylation; Oxidation

Indexed keywords

HUMAN SERUM ALBUMIN;

ACUTE LUNG INJURY; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CRITICAL ILLNESS; ELECTROSPRAY MASS SPECTROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; NITROSYLATION; OXIDATION; PRIORITY JOURNAL; SHOCK; TIME OF FLIGHT MASS SPECTROMETRY;

EID: 22144469136     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000169876.14858.91     Document Type: Article

References (17)

1. Quinlan GJ, Mumby S, Martin GS, et al: Albumin influences total plasma antioxidant capacity favorably in patients with acute lung injury. Crit Care Med 2004; 32:755-759
2. ABPI Compedium of Data Sheets and Summaries of Products Characteristics 1998-99. London, Association of the British Pharmaceutical Industries, 1998
3. Wilkes MM, Navickis RJ: Patient survival after human albumin administration. A meta-analysis of randomized, controlled trials. Ann Intern Med 2001; 135:149-164
4. Cochrane Injuries Group Albumin Reviewers: Human albumin administration in critically ill patients: Systematic review of randomized controlled trials. BMJ 1998; 317:235-240
5. Sort P, Navasa M, Arroyo V, et al: Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999; 341:403-409
6. von Hoegen I, Waller C: Safety of human albumin based on spontaneously reported serious adverse events. Crit Care Med 2001; 29:994-996
7. Finfer S, Bellomo R, Boyce N, et al: A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004; 350:2247-2256
8. Peters T: All About Albumin: Biochemistry, Genetics, and Medical Applications. First Edition. San Diego, Academic Press, 1996
9. Carballal S, Radi R, Kirk MC, et al: Sulfenic acid formation in human serum albumin by hydrogen peroxide and peroxynitrite. Biochemistry 2003; 42:9906-9914
10. Bar-Or D, Heyborne KD, Bar-Or R, et al: Cysteinylation of maternal plasma albumin and its association with intrauterine growth restriction. Prenat Diagn 2005; 25:245-249
11. Bar-Or D, Curtis CG, Sullivan A, et al: Plasma albumin cysteinylation is regulated by cystathionine beta-synthase. Biochem Biophys Res Commun 2004; 325:1449-1453
12. Gandley RE, Tyurin VA, Huang W, et al: S-nitrosoalbumin-mediated relaxation is enhanced by ascorbate and copper: Effects in pregnancy and preeclampsia plasma. Hypertension 2005; 45:21-27
13. Ng ES, Jourd'heuil D, McCord JM, et al: Enhanced S-nitroso-albumin formation from inhaled NO during ischemia/reperfusion. Circ Res 2004; 94:559-565
14. Bayir H, Kochanek PM, Liu SX, et al: Increased S-nitrosothiols and S-nitrosoalbumin in cerebrospinal fluid after severe traumatic brain injury in infants and children: Indirect association with intracranial pressure. J Cereb Blood Flow Metab 2003; 23:51-61
15. Bar-Or D, Rael LT, Lau EP, et al: An analog of the human albumin N-terminus (Asp-Ala-His-Lys) prevents formation of copper-induced reactive oxygen species. Biochem Biophys Res Commun 2001; 284:856-862
16. Bar-Or D, Curtis G, Rao N, et al: Characterization of the Co(2+) and Ni(2+) binding amino-acid residues of the N-terminus of human albumin. An insight into the mechanism of a new assay for myocardial ischemia. Eur J Biochem 2001; 268:42-47
17. Chevion M, Jiang Y, Har-El R, et al: Copper and iron are mobilized following myocardial ischemia: Possible predictive criteria for tissue injury. Proc Natl Acad Sci U S A 1993; 90:1102-1106